STERIS Announces Election of Jacqueline Kosecoff, PhD to Board of Directors
MENTOR, Ohio -- STERIS Corporation announces that Jacqueline Kosecoff, PhD has been elected to the company's board of directors. With the addition of Kosecoff, the STERIS board now consists of nine members.
Kosecoff serves as executive vice president of pharmaceutical services for PacifiCare, one of the nation's largest consumer health organizations. Prior to joining PacifiCare, Kosecoff founded Protocare, Inc., a firm involved in the development and testing of drugs, devices, biopharmaceutical and nutritional products, where she served for four years as the company's president. She is also the founder and former co-CEO and president of Value Health Sciences, a wholly owned subsidiary of Value Health, Inc., and co-founder of Chassin & Kosecoff Medical Systems.
Commenting on the election, Les C. Vinney, STERIS's president and CEO, said, "We are pleased to have Dr. Kosecoff join the STERIS board of directors. Jaqueline brings a wealth of business development and operations management experience gained in the healthcare and pharmaceutical industries. Her experience and unique background make her an excellent person to help STERIS achieve its long-term growth objectives. We look forward to working with Jaqueline and drawing upon her expertise and counsel."
Kosecoff earned a bachelor's degree from the University of California, Los Angeles (UCLA), a master's degree in applied mathematics from Brown University, and a PhD in research methods from UCLA. In addition to her entrepreneurial accomplishments, Kosecoff is an expert in quality of care assessment, has been published in several medical journals, and has served as professor of medicine and public health at UCLA, where she still holds a research professorship.
The mission of STERIS Corporation is to provide a healthier today and safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services.
Source: STERIS Corporation
Uncovering a Hidden Risk: Alcohol Use Disorder Significantly Increases C difficile Infection Rates
April 10th 2025A groundbreaking study reveals a strong connection between alcohol use disorder and increased risk for Clostridioides difficile infection, challenging traditional assumptions and calling for enhanced infection prevention protocols.
